Volume 38, Issue 39, 3 September 2020, Pages
Discussion Full text access
Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines
Rebecca Forman, Michael Anderson, Mark Jit, Elias Mossialos
:: Currently, unconditional investment is being made into COVID-19 vaccine R&D COVID-19 vaccine R&D investments should also ensure access and affordability.
:: The options market for antibiotics, could be adapted for use with COVID-19 vaccines.
:: This could help fund R&D, boost manufacturing capacity and secure fair prices.
:: Further research on the OMV model in the current COVID-19 crisis is warranted.